On 22 November 2024, Jean Georges, the Executive Director at Alzheimer Europe, was interviewed on Luxembourg radio station 100,7. He was invited to discuss the news that the Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency has re-evaluated its negative opinion on the treatment and gave a positive opinion on the drug, on 14 November 2024.
You can listen to the full interview (in Luxembourgish) here :
https://www.100komma7.lu/show/Moiesstudio/202411220822/episode/Hellef-bei-Alzheimer-am-Ufankstadium?pd=radio
